Navigation Links
Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference
Date:5/18/2009

CPF Recognized for Advancing Research and Patient Advocacy Efforts

SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this week. The ATS meeting brings together the world's leading pulmonary, critical care and sleep physicians. The CPF received an award for a partner grant program with ATS that, to date, has funded $400,000 in new pulmonary fibrosis research funding. The organization also received a first-time award for its participation in the ATS Public Advisory Roundtable (PAR). The CPF is exhibiting in booth #2921 on "PAR Row" at the International meeting.

The CPF has partnered with the ATS since 2006 to provide peer-reviewed grants for innovative research in PF. To date, the CPF/ATS partner grant program has awarded grants to PF researchers at Johns Hopkins University (Baltimore, MD), Massachusetts General Hospital (Boston, Mass.), Ohio State University Medical Center (Columbus, Ohio) and Vanderbilt University Medical Center (Nashville, Tenn.).

"We are pleased to receive some very prestigious awards from ATS, and we're proud to continue this exciting partnership with ATS," said Mishka Michon, CEO of the CPF.

The CPF received the ATS Foundation's inaugural "Breathing for Life Award" for its participation in the ATS PAR, the patient voice of the ATS. The ATS PAR has created unparalleled synergy with ATS members by involving patients in providing support, shaping public policy and stimulating new research.

Due to the CPF's involvement with ATS and combined efforts to further educate doctors and researchers on PF, the disease is gaining more attention and PF is the subject of an increasing number of high profile sessions at the international conference. Sessions on PF at this year's meeting have included topics ranging from basic research areas in lung stem cells as well as clinical and translational research from bench to bedside.

The CPF also awarded an ATS travel grant, provided to fund a PF researcher's conference travel, to James P. Bridges, Ph.D. from Cincinnati Children's Hospital and Medical Center.

For a schedule of ATS events, please visit http://www.thoracic.org/sections/meetings-and-courses/international-conference/2009/index.html.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring -- known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. United Concordia and Texas Oral Health Coalition Partner to Offer Free Dental Services
2. Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support
3. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
4. PhRMA Statement on Healthcare Reform Coalition
5. Bipartisan Coalition Forms to Call for Chronic Disease to be Key Focus of Health Reform in Indiana and Nationally
6. Latino Coalition Highlights Importance of Personal Health Records At Economic Summit
7. Industry Coalition Advises Against Use of Dietary Supplements as Swine Flu Remedy, Cure
8. Coalition Says On-Site Infectious Medical Waste Treatment Key To Disease Control and Hospital Sustainability During a Pandemic
9. Obama Judicial Nominee Opposed By Coalition of Disability Rights Organizations
10. Coalition of Leaders in Science and Research Commend Obama Administration for Commitment to Medical Innovation During First 100 Days
11. Coalition to Protect Senior Care Applauds Inclusion of Long Term Care in Senate Finance Committee Roundtable Discussion on Health Care Delivery System Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: